Below are the most recent publications written about "Uterine Cervical Dysplasia" by people in Profiles.
-
Anderson JR, Yogeshkumar S, Lu E, Yenokyan G, Thaler K, Mensa M, Chikaraddi S, Lokare L, Gudadinni MR, Antartani R, Donimath K, Patil B, Bidri S, Goudar SS, Derman R, Dalal A. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India. BJOG. 2023 Nov; 130(Suppl 3):158-167.
-
Yogeshkumar S, Anderson J, Lu E, Kenyi E, Mensa M, Thaler K, Antartani R, Donimath K, Patil B, Chikaraddi S, Bidri S, Biradar A, Gudadinni MR, Lokare L, Yenokyan G, Bellad MB, Goudar SS, Derman R, Revankar A, Patil H, Wani R, Kangle R, Chavan RY, Nagmoti MB, Kabadi YM, Reddy P, Vernekar S, Hipparagi S, Patil V, Dalal A. Safety and efficacy of the new CryoPop? cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls. Trials. 2021 Dec 13; 22(1):915.
-
Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih YT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society. CA Cancer J Clin. 2020 09; 70(5):321-346.
-
HooKim K, Lieberman RW, Smola BM, Knoepp SM. "Equivocal" high-risk HPV DNA tests performed on ThinPrep specimens after ASC-US diagnoses are associated with an increased incidence of CIN3: a cytologic/histologic review of 315 cases. J Low Genit Tract Dis. 2014 Oct; 18(4):291-7.
-
de la Cruz MS, Young AP, Ruffin MT. Human papillomavirus (HPV) testing for normal cervical cytology in low-risk women aged 30-65 years by family physicians. J Am Board Fam Med. 2013 Nov-Dec; 26(6):720-7.
-
Hoppenot C, Stampler K, Dunton C. Cervical cancer screening in high- and low-resource countries: implications and new developments. Obstet Gynecol Surv. 2012 Oct; 67(10):658-67.
-
Fleury AC, Birsner ML, Fader AN. Management of the abnormal Papanicolaou smear and colposcopy in pregnancy: an evidenced-based review. Minerva Ginecol. 2012 Apr; 64(2):137-48.
-
Berghella V, Bamfo J. Editors' choice. BJOG. 2011 Dec; 118(13):i-ii.
-
Fang CY, Miller SM, Bovbjerg DH, Bergman C, Edelson MI, Rosenblum NG, Bove BA, Godwin AK, Campbell DE, Douglas SD. Perceived stress is associated with impaired T-cell response to HPV16 in women with cervical dysplasia. Ann Behav Med. 2008 Feb; 35(1):87-96.
-
Syrj?nen K, Naud P, Derchain S, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Hammes LS, Matos J, Gontijo R, Sarian L, Braganca J, Arlindo FC, Maeda MY, L?rincz A, Dores GB, Costa S, Syrj?nen S. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res. 2005 Sep-Oct; 25(5):3469-80.